120 related articles for article (PubMed ID: 23571018)
1. Facing the dawn of immunotherapy for hepatocellular carcinoma.
Sprinzl MF; Galle PR
J Hepatol; 2013 Jul; 59(1):9-10. PubMed ID: 23571018
[No Abstract] [Full Text] [Related]
2. A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.
Sangro B; Gomez-Martin C; de la Mata M; Iñarrairaegui M; Garralda E; Barrera P; Riezu-Boj JI; Larrea E; Alfaro C; Sarobe P; Lasarte JJ; Pérez-Gracia JL; Melero I; Prieto J
J Hepatol; 2013 Jul; 59(1):81-8. PubMed ID: 23466307
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study.
Kolly P; Waidmann O; Vermehren J; Moreno C; Vögeli I; Berg T; Semela D; Zeuzem S; Dufour JF
J Hepatol; 2017 Oct; 67(4):876-878. PubMed ID: 28733219
[No Abstract] [Full Text] [Related]
4. Complete Response of Hepatocellular Carcinoma in a Patient With End-stage Liver Disease treated With Nivolumab: Whishful thinking or Possible?
Trojan J; Sarrazin C
Am J Gastroenterol; 2016 Aug; 111(8):1208-9. PubMed ID: 27481429
[No Abstract] [Full Text] [Related]
5. Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.
Moreno-Cubero E; Larrubia JR
World J Gastroenterol; 2016 Jul; 22(28):6469-83. PubMed ID: 27605882
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
Harding JJ; El Dika I; Abou-Alfa GK
Cancer; 2016 Feb; 122(3):367-77. PubMed ID: 26540029
[TBL] [Abstract][Full Text] [Related]
7. Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis C.
Kawaguchi T; Ide T; Koga H; Kondo R; Miyajima I; Arinaga-Hino T; Kuwahara R; Amano K; Niizeki T; Nakano M; Kuromatsu R; Torimura T
Clin J Gastroenterol; 2018 Feb; 11(1):69-74. PubMed ID: 29082453
[TBL] [Abstract][Full Text] [Related]
8. Unexpected viral relapses in hepatitis C virus-infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals.
Soria A; Fabbiani M; Lapadula G; Gori A
Hepatology; 2017 Sep; 66(3):992-994. PubMed ID: 28370176
[No Abstract] [Full Text] [Related]
9. Viral hepatitis and hepatocellular carcinoma: update in 2012.
Kudo M
Dig Dis; 2012; 30(6):539-40. PubMed ID: 23258091
[No Abstract] [Full Text] [Related]
10. Progression from chronic hepatitis to hepatocellular carcinoma: natural course and treatments.
Omata M; Yoshida H; Shiratori Y; Shiina S
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl 3():S434-6. PubMed ID: 12472977
[No Abstract] [Full Text] [Related]
11. [Hepatocellular carcinoma].
González-Huezo MS
Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():108-10. PubMed ID: 24041078
[No Abstract] [Full Text] [Related]
12. [Mechanism and clinical application of carcinogenesis control by IFN].
Yamamoto T; Nishiguchi S
Nihon Rinsho; 2006 Jul; 64(7):1254-8. PubMed ID: 16838641
[TBL] [Abstract][Full Text] [Related]
13. [What therapy is meaningful in chronic hepatitis C and resection of hepatocellular carcinoma for recurrence prophylaxis?].
Malfertheiner P
Dtsch Med Wochenschr; 2002 Nov; 127(48):2580. PubMed ID: 12457331
[No Abstract] [Full Text] [Related]
14. The patient with chronic hepatitis C.
Veerabagu MP; Casavilla A; Dodson F; Fung JJ; Rakela J
Liver Transpl Surg; 1996 Sep; 2(5 Suppl 1):73-8. PubMed ID: 9346706
[No Abstract] [Full Text] [Related]
15. Multimodal therapy for liver cirrhosis patients with advanced hepatocellular carcinoma.
Nagai H; Matsui T; Kanayama M; Wakui N; Momiyama K; Watanabe M; Igarashi Y; Sumino Y
Cancer Chemother Pharmacol; 2011 Jul; 68(1):139-45. PubMed ID: 20857114
[TBL] [Abstract][Full Text] [Related]
16. [Chronic hepatitis C virus infection: always treat!--Pro].
Zeuzem S
Dtsch Med Wochenschr; 2002 Sep; 127(36):1840. PubMed ID: 12215931
[No Abstract] [Full Text] [Related]
17. [Recent advances of non-surgical treatment of hepatocellular carcinoma].
Harada T
Nihon Naika Gakkai Zasshi; 1990 Sep; 79(9):1244-9. PubMed ID: 2175340
[No Abstract] [Full Text] [Related]
18. Ipilimumab-induced hepatitis C viral suppression.
Minter S; Willner I; Shirai K
J Clin Oncol; 2013 Jul; 31(19):e307-8. PubMed ID: 23690418
[No Abstract] [Full Text] [Related]
19. [Hepatocellular carcinoma in a patient with chronic hepatitis C without cirrhosis].
Plaza Santos R; Castillo Grau P; Castro Carbajo P; Olveira Martín A; Hidalgo Gutiérrez P; Segura Cabral JM
Rev Esp Enferm Dig; 2009 Jan; 101(1):71-2. PubMed ID: 19335037
[No Abstract] [Full Text] [Related]
20. [A small-sized hepatocellular carcinoma].
Barbare JC
Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B159-64. PubMed ID: 12843953
[No Abstract] [Full Text] [Related]
[Next] [New Search]
